A service of StreetInsider.com
Welcome

Most Popular

AAPL 222.25
C 3.90
GOOG 560.00
BAC 16.82
RIMM 73.06

Recently Added

WWIN 6.46
CCLTF 9.20
KCAP 5.51
NWM 0.01
CNYD 13.05

Gaining Speed

CNYD 13.05
KCAP 5.51
CCLTF 9.20
SGA 22.00
FGEXF 0.35
40.42 -0.36 (-0.88%) WPI

Click Here to Receive Instant E-mail and RSS Alerts

Stock Details

Last Trade:40.42 Change:-0.36 (-0.88%) Prev Close:40.78 Open: 40.83 Days Range:40.23 – 41.34 52 Week Range: 27.45 - 42.50 Volume:1423682 P/E: 20.62
EPS:1.96

Member Comments

No member comments available for WPI


Not logged in - Log in or Sign up to leave comments





View AllRecent Alerts 03/21/10

Recent Alert on 03/16/10 at 7:42am
Needham & Company Maintains an 'Underperform' on Watson Pharmaceuticals (WPI); Shares Already Discount Turnaround Dynamics

Needham & Company maintains an 'Underperform' rating on Watson Pharmaceuticals (NYSE: WPI). Needham analyst says, "Just when the Street appeared ready to lose all faith that the FDA would ever approve anything other than your stand... Read More

Recent Alert on 03/15/10 at 4:41pm
Watson Pharma (WPI) Subsidiary Get NDA from U.S. FDA for Ditiazem Hydrochloride XR Tablets
Recent Alert on 03/15/10 at 4:41pm
Watson Pharma (WPI) Subsidiary Get NDA from U.S. FDA for Ditiazem Hydrochloride XR Tablets
Recent Alert on 03/11/10 at 4:44pm
Watson Pharma (WPI) Gets U.S. FDA Approval for TRELSTAR 22.5-mg Prostate Cancer Treatment
Recent Alert on 03/11/10 at 4:44pm
Watson Pharma (WPI) Gets U.S. FDA Approval for TRELSTAR 22.5-mg Prostate Cancer Treatment

View AllRecent Press Releases

No Recent Press Releases Available

View AllRecent SEC Filings

SEC Filing on 03/17/10 at 4:13pm
Form 4 WATSON PHARMACEUTICALS For: Mar 16 Filed by: MUNRO GORDON
SEC Filing on 03/17/10 at 4:05pm
Form 4 WATSON PHARMACEUTICALS For: Mar 15 Filed by: TURNER ANDREW L

View AllRecent Blog Posts

Blog Posts on 03/18/10 at 3:25am
High Conviction: The Dominant Generic Drugmaker Will Widen Its Lead
Blog Posts on 03/16/10 at 3:51am
A Potential Option Straddle Trade
Blog Posts on 03/11/10 at 2:20pm
Is the Tide Turning Back in Takeda’s Favor?
Blog Posts on 02/28/10 at 2:10pm
Hedge Fund Bridger Management Is Bullish on Healthcare
Blog Posts on 02/25/10 at 5:07am
Watson Pharma: Income Statement Analysis for December 2009 Quarter